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Since the identification of Borrelia burgdorferias the agent ofLyme disease in 1982, 11 tick-borne human bacterial
pathogens have been described throughout Europe. These include five spotted fever rickettsiae, the agent of
human granulocytic ehrlichiosis, four species of the B. burgdorfericomplex and a new relapsing fever borrelia. We
present these emerging diseases and focus on the factors that playa role in the recognition of new tick-borne
diseases.
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Ticks are obligate hematophagous acarins that parasitize every
class of vertebrate throughout the world and may bite people
[1]. Since the beginning of the century, ticks have been
described as vectors of human diseases, including bacterial
(spotted fever rickettsioses, recurrent fever borrelioses, tular-
emia, Q fever) [2,3], viral [3,4] and protozoan [3,5] zoonoses.
However, the major impact of ticks on public health was
recognized with the identification and emergence of B. burg-
dorferi as the etiologic agent of Lyme disease in 1982, which
brought the subj ect to general attention. Currently, there is an
increasing awareness of tick-borne diseases, and efforts of both
clinicians and researchers have led to the recent description of
emerging tick-borne bacterial diseases, particularly in Europe
(Figure 1).
Each tick species that may act as a vector favors particular
optimal environmental conditions and biotopes. These deter-
mine the geographic distribution of the ticks and consequently
the risk area for tick-borne diseases. This is particularly true
when ticks are not ouly vectors, but also reservoirs ofpathogens;
this is the case for rickettsioses. The Mediterranean spotted
fever ('boutonneuse' fever) caused by Rickettsia conorii and
transmitted by the brown dog tick Rhipicephalus sanguineus is
encountered in summer in the Mediterranean area. Until
recently it was thought to be the ouly rickettsiosis prevalent
in Europe. The onset of signs is abrupt, and typical cases have a
high fever, a rash and a unique eschar (the 'tache noire') at the
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tick bite site [6]. However, five newly recognized tick-borne
rickettsioses have been described throughout Europe during the
past 9 years. In 1991, the causative agent ofAstrakhan fever was
described as a rickettsia closely related to, but distinct from,
Rickettsia conorii. The suspected vector of this eruptive summer
disease occurring in Astrakhan on the Caspian Sea is the dog
tick Rhipicephalus pumilio [6]. In March 1996, a 63-year-old
woman from Marseille presented with a fever, a discrete rash
and an eschar in her left groin. A rickettsia previously isolated
from Hyalomma asiaticum ticks in Mongolia was obtained from
the blood and the skin of the patient. She had no previous travel
history, and risk factors for tick bites included ouly the collec-
tion of compost from a garden where migratory birds were
resting. It was hypothesized that the birds could have trans-
ported the rickettsia, and the name Rickettsia mongolotimonae was
proposed [7]. A second case was described in May 1998 in an
HIV patient who had been gardening in a rural area of
Marseille. This patient presented with fever, headache, an
eschar, lymphangitis and painful satellite lymphadenopathy
[8]. Since then, two other cases have been documented in
southern France, and Rickettsia mongolotimonae has been
detected in Hyalomma truncatum collected from cattle in sub-
Saharan Africa (unpublished data). Thus, Rickettsia mongoloti-
monae may be specifically associated with Hyalomma sp. ticks. In
southern France, the vector has yet to be described, but
Hyalomma spp. are known to parasitize birds and mammals in
this area.
In 1997, the first documented case of infection due to
Rickettsia slovacawas reported in a woman bitten by Dermacentor
marginatus in France [9]. The woman had presented with fever
and an eschar at the site of the tick's attachment on the scalp,
which was surrounded by an extensive erythema. She also had
enlarged cervical lymph nodes and suffered from fatigne.
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Figure 1 Geographic distribution of tick-borne rickettsioses, ehrlichioses and borrelioses in Europe. B. veleisiene is strongly suspected to be a pathogen.
Similar undocumented cases had previously been reported in
France, Slovakia and Hungary, where this clinical syndrome was
known as 'Tibola' (for tick-borne lymphadenopathy). Rickettsia
slovaca was found in all European countries where D. marginatus
was screened for rickettsial infections, including France, Swit-
zerland, Slovakia, Ukraine, Yugoslavia, Armenia and Portugal
[10]. To date, 25 cases have been documented in patients from
France and Hungary presenting with tick bites on the scalp and
lymphadenopathy (unpublished data). Fever is uncommon, and
sequelae include localized alopecia at the bite site and chronic
fatigue. D. marginatus and D. reticulatus are potential vectors.
Both species are prevalent throughout Europe to central Asia
(except for D. marginatus, which has not been identified in
northern Europe). Adult ticks inhabit forests and pastures. They
may feed on humans and frequently bite the scalp. They are
active during early spring, again in autumn and even in winter
in southern Europe.
More recently, Rickettsia helvetica was implicated in 1999 in
fatal perimyocarditis in young patients in Sweden [11]. This
bacterium was detected by peR in the pericardium and in a
lymph node from the pulmonary hilum in the first patient, and
in a coronary artery and the heart muscle in the second patient.
Electron microscopy yielded a rickettsia-like organism predo-
minantly located in the endothelium, and the patients' sera
reacted with spotted fever group ricketrsia antigens. We also
reported the case ofa French patient who seroconverted against
Rickettsia helvetica 4 weeks after the onset of an unexplained
febrile illness [12]. The vector is Ixodes ricinus, which is also the
vector of Lyme borreliosis and distributed throughout Europe,
particularly in forests. In addition, we recently described a
seroprevalence of 9.2% against Rickettsia helvetica among forest
workers from the area where the patient lived. More recently, in
1999 Israeli spotted fever caused by a rickettsia closely related to
Rickettsia conorii and which is known to occur in Israel was
identified in Sicily and Portugal [13]. It is transmitted by
Rhipicephalussanguineus. The inoculation eschar is usually lack-
ing and the disease may be severe. Finally, European clinicians
have to consider the new rickettsioses described throughout the
world that may present as imported diseases, particularly African
tick bite fever caused by Rickettsia africae in patients returning
from sub-Saharan Africa or the West Indies [14,15]. In a
prospective study conducted among more than 800 Norwegian
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travelers returning from rural Africa, around 3% had clinical
signs and serologic tests consistent with African tick bite fever
(M. Jensenius, unpublished data).
In recent years, human granulocytic ehrlichiosis (HGE) has
also emerged in Europe. This disease was first described in the
USA in 1994 and presents most commonly as an undifferen-
tiated, febrile, potentially severe illness occurring in summer or
spring [16]. The causative organism is very closely related to
Ehrlichia equi and E. phagocytophila (pathogens of horses and
ruminants, respectively). Although seroepidemiologic studies
led to the suspicion that HGE occurs in most European
countries with a prevalence of 0-2% in blood donors and 5-
25% of tick-exposed people, the first documented case was
reported in Slovenia in 1997 [17]. Since then, six cases have
been confirmed in Slovenia, three in Sweden, and one in The
Netherlands, and serologically documented cases have been
reported in Spain [18-20]. The tick vector ofHGE in Europe is
Ixodes ricinus. Small mammals, in particular Apodemus sylvaticus
(wood mouse), Apodemus fiavicollis (yellow-necked mouse),
Sorex araneus (common shrew) and Clethrinomysglareolus (bank
vole), have recently been implicated as reservoirs of granulo-
cytic ehrlichiae in Europe [21]. To date, there are no convincing
reports on the presence in Europe of the two other known
human ehrlichioses, including the human monocytic ehrlichio-
sis caused by E. chaffeensis and the infection caused by E. ewingii,
which have been described in the USA [16,22].
New data have also been obtained on tick-borne borrelioses.
Lyme borreliosis is caused by three ofthe 10 described species in
the B. burgdoferi sensu lato complex: B. burgdorferi sensu stricto,
B. garinii and B. afzelli. Differences appeared in the organo-
tropism of these Borrelia species. B. afzelii is associated with
erythema migrans and a milder disease than that caused by B.
burgdorferi sensu stricto. It is also the principal cause of acro-
dermatitis chronica atrophicans and a cause of borrelial lym-
phocytoma. Infections with B. garinii are more frequently
associated with neurologic forrns of the diseases, while those
with B. burgdorferi sensu stricto are more often associated with
rheumatologic disorders [23]. In Europe, Apodemus species are
considered to be the most important reservoirs of the bacteria.
Various species of birds, especially ground-foraging birds, have
also been incriminated as reservoirs. Although each pathogenic
species of Borrelia has been found to be associated with birds in
Europe, B. afzelii is thought to be perpetuated in rodents and B.
garinii in avian reservoir hosts [24]. Recently, a novel isolate
(A14S) ofthe B. burgdoferi sensu lato complex has been detected
from a skin biopsy of a patient with erythema migrans in The
Netherlands [25]. Furthermore, a pathogenic role for B. valaisi-
ana that occurs in Europe and Asia is suspected [26]. Finally,
although relapsing fever borrelioses transmitted by soft ticks of
the genus Ornithodoros have long been recognized as human
diseases, some species, including the African B. duttonii and B.
aocidurae, have only recently been cultured. In southern Europe,
recurrent fever due to B. hispanica is reported sporadically, and a
new species pathogenic to humans was isolated and character-
ized in Spain in 1996 [27].
The increase in outdoor activities among Europeans has
resulted in increased contact with ticks and increased risk of
transmitted diseases. However, numerous factors are playing a
role in the recognition of new tick-borne diseases. Although
serology is ofmost value in the diagnosis of a tick-borne disease,
a major limitation is cross-reactivity [28]. For example, it is
frequently not possible to differentiate among spotted fever
rickettsiae or granulocytic ehrlichiae. The development of new
techniques, including the shell-vial assay for the isolation of
organisms and molecular methods for their characterization, has
improved the specific diagnosis of tick-borne bacterial diseases.
Methods based on PCR gene amplification have made possible
the development of useful, sensitive and rapid tools to detect
and identity tick-borne pathogens from blood, ticks and skin
biopsy specimens [2,29]. It is relatively simple for a laboratory to
detect and identity bacteria (including new strains) if there are
facilities for molecular methods and access to sequence data.
Modern diagnostic methods combined with the curiosity of
clinicians about atypical cases are the keys to the recognition of
new diseases.
For example, Astrakhan fever was found in an area where
spotted fever group rickettsiae were not known to occur. The
presence ofan inoculation eschar in patients presenting with an
eruptive febrile disease led to the suspicion of a rickettsiosis.
Although some physicians in Astrakhan were doubtful about
this hypothesis, it was proved by the use of a modern cell-
culture system and molecular tools in Moscow. Moreover, the
study of atypical cases in France, where Rickettsia conorii was
thought to be the ouly pathogenic rickettsia, led to the recog-
nition of the pathogenicity of Rickettsia mongolotimonae. The
patient presented in March, an atypical month for Mediterra-
nean spotted fever, and molecular methods were critical in
incriminating this bacterium, which had previously been
detected in ticks ouly. These methods also contributed to
the description of new clinical syndromes caused by organisms
that had previously been considered as I rickettsiae of unknown
pathogenicity', including Rickettsiaslovaca and Rickettsiahelvetica.
To date, numbers ofrickettsiae, borreliae, ehrlichiae and even
bartonellae have been found in ticks ouly [6,30]. Their patho-
genicity in people is yet to be determined, but they represent
potential candidates for new tick-borne diseases to be described
in the future. The public has to be informed about the
avoidance of tick-infested areas and about measures that are
known to decrease the risk of tick bites, including the use oftick
repellents [2]. Physicians must keep in mind the importance of
promptly treating patients presenting with acute febrile illnesses
after tick bites. Doxycycline is effective against all known
bacterial pathogens transmitted by ticks and should be started
in symptomatic patients before the diagnostic results [2].
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